新辅助大剂量化疗联合自体外周血干细胞移植治疗对标准剂量化疗耐药的不可切除复发性颈部脂肪肉瘤 - Suppr | 超能文献

Neo-adjuvant high-dose chemotherapy with autologous peripheral blood stem cell transplantation for inoperable relapse of nuchal liposarcoma resistant to standard-dose chemotherapy.

作者信息

Fetscher S, Kiani A, Kanz L, Brugger W, Lange W, Mertelsmann R

出版信息

Ann Oncol. 1996 Oct;7(8):871. doi: 10.1093/oxfordjournals.annonc.a010772.

DOI:10.1093/oxfordjournals.annonc.a010772

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Neo-adjuvant high-dose chemotherapy with autologous peripheral blood stem cell transplantation for inoperable relapse of nuchal liposarcoma resistant to standard-dose chemotherapy.新辅助大剂量化疗联合自体外周血干细胞移植治疗对标准剂量化疗耐药的不可切除复发性颈部脂肪肉瘤

Ann Oncol. 1996 Oct;7(8):871. doi: 10.1093/oxfordjournals.annonc.a010772.

2

Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?大剂量化疗及自体外周血干细胞移植后粒细胞集落刺激因子的应用：最佳时机是什么？

Am J Clin Oncol. 2001 Feb;24(1):19-25. doi: 10.1097/00000421-200102000-00003.

3

A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study Group.一项关于来格司亭（糖基化重组人粒细胞集落刺激因子）用于乳腺癌患者术后辅助化疗期间外周血干细胞动员的剂量探索性研究。来格司亭/乳腺癌研究组。

Jpn J Clin Oncol. 1999 Jun;29(6):285-90. doi: 10.1093/jjco/29.6.285.

4

The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone.

Cancer Treat Rev. 1998 Jun;24(3):173-84. doi: 10.1016/s0305-7372(98)90048-2.

5

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.粒细胞集落刺激因子与粒细胞巨噬细胞集落刺激因子联合强化化疗用于多发性骨髓瘤外周血干细胞动员和自体移植的随机对照研究

Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001.

6

A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.一项关于紫杉醇联合顺铂作为头颈部癌一线治疗的I/II期研究：初步结果。

Semin Oncol. 1995 Dec;22(6 Suppl 15):50-4.

7

Liposarcoma of the neck.颈部脂肪肉瘤

Arch Otolaryngol. 1968 Oct;88(4):419-22. doi: 10.1001/archotol.1968.00770010421015.

8

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.诱导期持续时间和高剂量周期数对接受含干细胞救援的高剂量化疗的转移性乳腺癌女性长期生存的影响：来自达纳-法伯/贝斯以色列女执事医疗中心STAMP项目的序贯I/II期试验分析

Biol Blood Marrow Transplant. 2002;8(4):198-205. doi: 10.1053/bbmt.2002.v8.pm12017145.

9

Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group.晚期实体瘤患者采用外周血干细胞支持及造血生长因子辅助的双周期大剂量化疗。香港生物治疗组的一项初步研究。

Cancer. 1994 Apr 1;73(7):1960-70. doi: 10.1002/1097-0142(19940401)73:7<1960::aid-cncr2820730730>3.0.co;2-h.

10

Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.卵巢癌中造血生长因子支持下的化疗剂量递增

Semin Oncol. 1994 Dec;21(6 Suppl 16):44-50.

引用本文的文献

1

Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.非横纹肌肉瘤软组织肉瘤大剂量化疗后的自体造血干细胞移植。

Cochrane Database Syst Rev. 2013 Aug 7;2013(8):CD008216. doi: 10.1002/14651858.CD008216.pub4.